Immix Biopharma, Inc.
IMMX
$1.96
-$0.07-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.45% | -67.01% | -22.84% | -112.08% | -33.94% |
| Total Depreciation and Amortization | 1,232.26% | 1,750.00% | 4,760.00% | 4,680.00% | 416.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.35% | 8.86% | 46.79% | 179.59% | 328.03% |
| Change in Net Operating Assets | 81.80% | 353.92% | -313.99% | 610.45% | 525.46% |
| Cash from Operations | 44.86% | -30.76% | -49.52% | -82.93% | 31.42% |
| Capital Expenditure | -3,742.42% | -597.94% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3,742.42% | -597.94% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -100.00% | -100.00% | 15,249.95% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | -100.00% | -100.00% | -100.00% | 13,313.46% | 38.27% |
| Foreign Exchange rate Adjustments | -180.19% | 294.92% | -36.88% | -1,633.33% | 15,750.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.09% | -161.84% | -548.90% | 698.37% | 40.44% |